New York-based longevity science company Elysium Health Inc announced on Wednesday that it has introduced VISION by Elysium Health for eye longevity, performance, and protection.

The product was developed with the guidance of Theodore Leng, MD, a retinal specialist, ophthalmologist, and director of Clinical and Translational Research at the Byers Eye Institute at Stanford University School of Medicine.

According to the company, VISION by Elysium Health is formulated to support visual performance and eye health at every stage of life and is based on the latest research on xanthophyll carotenoids -- plant pigments that accumulate in the eye and provide powerful antioxidant defence and photoprotection -- with Elysium Health's Protective Intervention for Xanthin-based Eye Longevity (PIXEL) Complex.